XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.23.2

CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES | 6 Months Ended
--- | ---
Jun. 30, 2023
Cash and Cash Equivalents [Abstract] |
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES | CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES The following tables summarize the fair value of cash, cash equivalents and marketable securities as well as gross unrealized holding gains and losses as of June 30, 2023 and December 31, 2022:
| June 30, 2023
| Amortized cost |  | Gross unrealized holding gains |  | Gross unrealized holding losses |  | Fair value
Cash | $ | 868,598 |  |  | $ | — |  |  | $ | — |  |  | $ | 868,598 |
Cash equivalents(1) | 70,754,658 |  |  | 5,208 |  |  | — |  |  | 70,759,866 |
Marketable securities | 24,888,936 |  |  | — |  |  | — |  |  | 24,888,936 |
Total cash, cash equivalents and marketable securities | $ | 96,512,192 |  |  | $ | 5,208 |  |  | $ | — |  |  | $ | 96,517,400 |
(1)Cash equivalents as of June 30, 2023 include money market funds of $40.9 million.
| December 31, 2022
| Amortized cost |  | Gross unrealized holding gains |  | Gross unrealized holding losses |  | Fair value
Cash | $ | 2,853,042 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,853,042 |
Money market funds | 42,014,804 |  |  | — |  |  | — |  |  | 42,014,804 |
Marketable securities | 84,175,752 |  |  | — |  |  | (42,187) |  |  | 84,133,565 |
Total cash, cash equivalents and marketable securities | $ | 129,043,598 |  |  | $ | — |  |  | $ | (42,187) |  |  | $ | 129,001,411 |
The Company did not hold any securities that were in an unrealized loss position for more than 12 months as of June 30, 2023 and December 31, 2022. There were no material realized gains or losses on available-for-sale securities during the three and six months ended June 30, 2023 and 2022.

X
- References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 13 -Subparagraph (d)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13 + Details
Name: | us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration